Payer

Payers are lagging behind other industries that use technology to offer seamless digital experiences to customers, and it's costing them money and members, according to a new study from Forrester and Smart Communications.

The Federal Trade Commission has begun an investigation into San Francisco-based Cerebral, The Wall Street Journal reported June 15.

Jared Lorinsky is chief strategy officer at Burlington, Mass.-based HealthEdge. He's been working in the payer reimbursement and payment integrity sphere for around two decades and sat down with Becker's to discuss how payers can use new technology and innovations…

New Mexico medical cannabis company Top Organics-Ultra Health and six medical patients have filed a proposed class action against seven payers they say should be covering medical cannabis costs as a behavioral health service.

A new observational study has linked high-deductible health plans with delays in the detection of metastatic cancer, according to Healio.

From being selected for a Medicare Advantage contract with Connecticut, to canceling its contract with Cerebral, Hartford, Conn.-based Aetna has been featured in seven recent Becker's stories:

Twelve officials make up Louisville-Ky.-based Humana's executive team, according to the payer's website. 

Centene has agreed to pay $13.7 million to settle an investigation into its subsidiaries' pricing and reporting of pharmacy benefits and services to New Mexico's Medicaid program.   

Optum is canceling in-network services with mental health startup Cerebral in August, a spokesperson for UnitedHealth Group's behavioral health arm told Business Insider on June 13. 

Humana's pharmacy and specialty pharmacy businesses are now under its CenterWell brand.